FDA Inspection 1249201 — Genentech, Inc.
The FDA completed an inspection of Genentech, Inc. on Aug 16, 2024 in Oceanside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Oceanside, CA (United States)